259 related articles for article (PubMed ID: 21628934)
21. [Differentiation between hyperintense hepatocellular carcinoma and focal nodular hyperplasia in hepatobiliary phase with multimodal parameters of magnetic resonance imaging].
Lang Y; Ma CQ; Deng LW; Wang J; Liu C; Xiao SL; Deng J; Li Q; Liu WW; Yang DS; Li XM
Zhonghua Gan Zang Bing Za Zhi; 2022 Oct; 30(10):1069-1073. PubMed ID: 36727231
[No Abstract] [Full Text] [Related]
22. Ring-like enhancement of focal nodular hyperplasia with hepatobiliary-phase Gd-EOB-DTPA-enhanced magnetic resonance imaging: radiological-pathological correlation.
Fujiwara H; Sekine S; Onaya H; Shimada K; Mikata R; Arai Y
Jpn J Radiol; 2011 Dec; 29(10):739-43. PubMed ID: 22009428
[TBL] [Abstract][Full Text] [Related]
23. HBP-enhancing hepatocellular adenomas and how to discriminate them from FNH in Gd-EOB MRI.
Auer TA; Walter-Rittel T; Geisel D; Schöning W; Schmelzle M; Müller T; Sinn B; Denecke T; Hamm B; Fehrenbach U
BMC Med Imaging; 2021 Feb; 21(1):28. PubMed ID: 33588783
[TBL] [Abstract][Full Text] [Related]
24. [The application value of Gd-EOB-DTPA enhanced MRI based radiomics in the differential diagnosis of iso-or hyperintensity HCC and focal nodular hyperplasia in hepatobiliary phase].
Mao HY; Yu YX; Zhang JY; Zhang T; Fan YF; Hu S; Wang XM; Hu CH
Zhonghua Yi Xue Za Zhi; 2023 Sep; 103(33):2599-2606. PubMed ID: 37650206
[No Abstract] [Full Text] [Related]
25. Gd-EOB-DTPA MRI for focal nodular hyperplasia-like lesions in pediatric cancer survivors.
Gu K; Jeon TY; Yoo SY; Kim JH
Eur Radiol; 2021 Jan; 31(1):283-291. PubMed ID: 32797310
[TBL] [Abstract][Full Text] [Related]
26. Benign nodules in post-Fontan livers can show imaging features considered diagnostic for hepatocellular carcinoma.
Wells ML; Hough DM; Fidler JL; Kamath PS; Poterucha JT; Venkatesh SK
Abdom Radiol (NY); 2017 Nov; 42(11):2623-2631. PubMed ID: 28785785
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic performance and description of morphological features of focal nodular hyperplasia in Gd-EOB-DTPA-enhanced liver magnetic resonance imaging: results of a multicenter trial.
Zech CJ; Grazioli L; Breuer J; Reiser MF; Schoenberg SO
Invest Radiol; 2008 Jul; 43(7):504-11. PubMed ID: 18580333
[TBL] [Abstract][Full Text] [Related]
28. Serum amyloid A and C-reactive protein positive nodule in alcoholic liver cirrhosis, hard to make definite diagnosis.
Kim SR; Kondo F; Otono Y; Imoto S; Ando K; Hirakawa M; Fukuda K; Sasaki M; Kim SK; Komaki T; Tsuchida S; Kobayashi S; Matsuoka T; Kudo M
Hepatol Res; 2014 May; 44(5):584-90. PubMed ID: 23607539
[TBL] [Abstract][Full Text] [Related]
29. Correlation between Gd-EOB-DTPA-enhanced MR imaging findings and OATP1B3 expression in chemotherapy-associated sinusoidal obstruction syndrome.
Yoneda N; Matsui O; Ikeno H; Inoue D; Yoshida K; Kitao A; Kozaka K; Kobayashi S; Gabata T; Ikeda H; Nakamura K; Ohta T
Abdom Imaging; 2015 Oct; 40(8):3099-103. PubMed ID: 26187715
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic value of morphological enhancement patterns in the hepatobiliary phase of gadoxetic acid-enhanced MRI to distinguish focal nodular hyperplasia from hepatocellular adenoma.
Bilreiro C; Soler JC; Ayuso JR; Caseiro-Alves F; Ayuso C
Radiol Med; 2021 Nov; 126(11):1379-1387. PubMed ID: 34287759
[TBL] [Abstract][Full Text] [Related]
31. MRI for characterization of benign hepatocellular tumors on hepatobiliary phase: the added value of in-phase imaging and lesion-to-liver visual signal intensity ratio.
Lebert P; Adens-Fauquembergue M; Azahaf M; Gnemmi V; Behal H; Luciani A; Ernst O
Eur Radiol; 2019 Nov; 29(11):5742-5751. PubMed ID: 30993437
[TBL] [Abstract][Full Text] [Related]
32. The diagnosis of hypovascular hepatic lesions showing hypo-intensity in the hepatobiliary phase of Gd-EOB- DTPA-enhanced MR imaging in high-risk patients for hepatocellular carcinoma.
Nakamura S; Nouso K; Kobayashi Y; Shiraha H; Ohnishi H; Toshimori J; Kuwaki K; Hagihara H; Takayama H; Yamamoto K
Acta Med Okayama; 2013; 67(4):239-44. PubMed ID: 23970322
[TBL] [Abstract][Full Text] [Related]
33. Effect of change in transporter expression on gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging during hepatocarcinogenesis in rats.
Tsuda N; Harada K; Matsui O
J Gastroenterol Hepatol; 2011 Mar; 26(3):568-76. PubMed ID: 21332553
[TBL] [Abstract][Full Text] [Related]
34. Differentiation of focal nodular hyperplasia from hepatocellular adenoma: Role of the quantitative analysis of gadobenate dimeglumine-enhanced hepatobiliary phase MRI.
Roux M; Pigneur F; Calderaro J; Baranes L; Chiaradia M; Tselikas L; Decaens T; Costentin C; Laurent A; Azoulay D; Mallat A; Zafrani ES; Rahmouni A; Luciani A
J Magn Reson Imaging; 2015 Nov; 42(5):1249-58. PubMed ID: 25851028
[TBL] [Abstract][Full Text] [Related]
35. Arterial enhancing-only nodules less than 2 cm in diameter in patients with liver cirrhosis: predictors of hepatocellular carcinoma diagnosis on gadobenate dimeglumine-enhanced MR imaging.
Quaia E; Pizzolato R; De Paoli L; Angileri R; Ukmar M; Cova MA
J Magn Reson Imaging; 2013 Apr; 37(4):892-902. PubMed ID: 23097278
[TBL] [Abstract][Full Text] [Related]
36. Serum amyloid A-positive hepatocellular neoplasms in the resected livers from 3 patients with alcoholic cirrhosis.
Sasaki M; Kondo F; Sawai Y; Imai Y; Kadowaki S; Sano K; Fukusato T; Matsui O; Nakanuma Y
Histol Histopathol; 2013 Nov; 28(11):1499-505. PubMed ID: 23690168
[TBL] [Abstract][Full Text] [Related]
37. Presence of non-hypervascular hypointense nodules on Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in patients with hepatocellular carcinoma.
Inoue M; Ogasawara S; Chiba T; Ooka Y; Wakamatsu T; Kobayashi K; Suzuki E; Tawada A; Yokosuka O
J Gastroenterol Hepatol; 2017 Apr; 32(4):908-915. PubMed ID: 27787908
[TBL] [Abstract][Full Text] [Related]
38. Comparison of Contrast-Enhanced Ultrasound and Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced MRI for the Diagnosis of Macroscopic Type of Hepatocellular Carcinoma.
Iwamoto T; Imai Y; Kogita S; Igura T; Sawai Y; Fukuda K; Yamaguchi Y; Matsumoto Y; Nakahara M; Morimoto O; Seki Y; Ohashi H; Fujita N; Kudo M; Takehara T
Dig Dis; 2016; 34(6):679-686. PubMed ID: 27750237
[TBL] [Abstract][Full Text] [Related]
39. Focal hepatic lesions in Gd-EOB-DTPA enhanced MRI: the atlas.
Campos JT; Sirlin CB; Choi JY
Insights Imaging; 2012 Oct; 3(5):451-74. PubMed ID: 22700119
[TBL] [Abstract][Full Text] [Related]
40. Characterization of the arterial enhancement pattern of focal liver lesions by multiple arterial phase magnetic resonance imaging: comparison between hepatocellular carcinoma and focal nodular hyperplasia.
Gatti M; Calandri M; Bergamasco L; Darvizeh F; Grazioli L; Inchingolo R; Ippolito D; Rousset S; Veltri A; Fonio P; Faletti R
Radiol Med; 2020 Apr; 125(4):348-355. PubMed ID: 31916102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
